Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Suppression of Ovulation: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Suppression of Ovulation: 1 US clinical trial tracked, none currently recruiting.

Suppression of Ovulation is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Kimberly Myer, running 1 of these trials.

Enrollment posture brief

Registry condition suppression-of-ovulation

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Suppression of Ovulation (th…0%
Open-enrollment share among volume-matched conditions near Suppression of Ovulation

Suppression of Ovulation has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Suppression of Ovulation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Suppression of Ovulation is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Kimberly Myer 1 trials

Named interventions

Most-linked intervention names on Suppression of Ovulation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

40 µg/day E2 with NES 200® µg/day Drug
1 trials
20 µg/day E2 with NES 200® µg/day Drug
1 trials
10 µg/day E2 with NES 200® µg/day Drug
1 trials

US sites by state

Facility locations filed on Suppression of Ovulation trials. A trial with sites in several states counts in each.

Virginia 1 trials
Pennsylvania 1 trials
Oregon 1 trials
Ohio 1 trials
New York 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Suppression of Ovulation page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Suppression of Ovulation trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Kimberly Myer sponsors the most Suppression of Ovulation trials on record, review their full trial history before evaluating a specific study. See Kimberly Myer's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Suppression of Ovulation condition card totals 1 registered trials; most-linked intervention 40 µg/day E2 with NES 200® µg/day; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.